Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review
This narrative review aims to provide an overview of the current literature on the pharmacology, safety, efficacy and tolerability of intranasal esketamine, the S-enantiomer of ketamine, for the treatment of treatment-resistant depression (TRD). A literature search using Medline, Embase, PsycINFO an...
Saved in:
Main Authors: | Mohammed S Salahudeen (Author), Cameron M Wright (Author), Gregory M Peterson (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
by: Simone Pardossi, et al.
Published: (2024) -
Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
by: Lorena Catarina Del Sant, et al.
Published: (2022) -
New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment-a narrative review
by: Małgorzata Satora, et al.
Published: (2024) -
Computer-Based Simulators in Pharmacy Practice Education: A Systematic Narrative Review
by: Ahmed M. Gharib, et al.
Published: (2023) -
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States
by: Lisa Harding, et al.
Published: (2024)